8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2020 / Meta-analysis of randomized controlled trials
A meta-analysis of 16 randomized controlled trials with 572 participants evaluated the effects of pomegranate supplementation compared to placebo. Pomegranate intake significantly lowered hs-CRP (WMD: -6.57 mg/L, 95% CI: -10.04 to -3.10), IL-6 (WMD: -1.68 pg/mL, 95% CI: -3.52 to 0.157), and TNF-alpha (WMD: -2.37 pg/mL, 95% CI: -3.67 to -1.07). However, no significant effects were observed for CRP, E-selectin, ICAM, VCAM, or MDA.
Wang P, Zhang Q, Hou H, et al. Complement Ther Med, 2020. PMID 32147056
2020 / Systematic review of human and animal studies
A systematic review evaluated the impact of apple vinegar on metabolic parameters, body weight, safety, and side effects across 13 human and 12 animal studies. Researchers noted that while beneficial health effects may exist and the risk of side effects appears inconsiderable when ingested in recommended quantities and ways, current evidence remains insufficient. The authors concluded that more large-scale, long-term clinical studies with a low risk of bias are needed before definitive conclusions can be drawn.
Launholt TL, Kristiansen CB, Hjorth P Eur J Nutr, 2020. PMID 32170375
2020 / Meta-analysis of randomized controlled trials
A meta-analysis of 14 randomized controlled trials with 1,137 participants compared the effects of EPA/DHA versus ALA supplementation on cardiometabolic outcomes. Compared with ALA, EPA/DHA supplementation resulted in a greater reduction in triglycerides (WMD -0.191 mmol l-1; 95% CI -0.249, -0.133), but greater increases in HDL (WMD 0.033 mmol l-1; 95% CI 0.004, 0.062), LDL (WMD 0.130 mmol l-1; 95% CI 0.006, 0.253), and total cholesterol (WMD 0.179 mmol l-1; 95% CI 0.006, 0.352). When administered separately, modest HDL increases were observed with DHA supplementation (0.161 mmol l-1; 95% CI 0.017, 0.304), but not with EPA (0.040 mmol l-1; 95% CI -0.132, 0.212).
Chen H, Deng G, Zhou Q, et al. Food Funct, 2020. PMID 32175534
2020 / Cohort study and meta-analysis of prospective cohort studies
In an NHANES cohort of 24,856 participants (mean follow-up 6.4 years, 3,433 deaths), higher potato consumption was initially associated with higher risks of total (42%), CVD (65%), cerebrovascular (26%), and cancer (52%) mortality (p < 0.001), but these associations disappeared after adjustment for confounding factors. In a pooled meta-analysis of prospective studies (98,569 participants), potato intake showed no significant association with total (RR = 1.25, 95% CI 0.98-1.60), CVD (RR = 0.99, 95% CI 0.90-1.08), or stroke mortality (RR = 0.94, 95% CI 0.85-1.03). However, individuals with higher potato intake displayed less favorable cardiometabolic profiles, including higher waist circumference (97.2 vs. 99.5 cm) and worse blood pressure, triglycerides, HDL-C, and TG/HDL-C ratio (all p < 0.001).
Shows an association, not proof of cause and effect.
Mazidi M, Katsiki N, Mikhailidis DP, et al. Arch Med Sci, 2020. PMID 32190135
2020 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis of randomized controlled trials evaluated the effects of dark chocolate and flavonoids on flow-mediated dilatation (FMD). Chronic intake of dark chocolate increased FMD (0.69, 95% CI 0.22-1.16, p < 0.001), as did flavan-3-ols (1.16, 95% CI 0.52-1.80, p = 0.001). Acute consumption of dark chocolate also improved FMD (p < 0.001). A non-linear dose-response was detected for chronic dark chocolate intake, while flavonoid intake over 40 g/day increased FMD, peaking around 40-60 g/day.
Ebaditabar M, Djafarian K, Saeidifard N, et al. Clin Nutr ESPEN, 2020. PMID 32220363
2020 / Participant-level meta-analysis of 3 prospective cohort studies
Researchers conducted a participant-level meta-analysis of three US cohorts (Health ABC, MESA, and Framingham Offspring) to evaluate circulating phylloquinone (vitamin K-1) categories (≤0.5, >0.5-1.0, and >1.0 nmol/L) in relation to CVD and mortality over a median of 13.0 years. Among 3,891 participants, 858 incident CVD events and 1,209 deaths occurred. CVD risk did not significantly differ by phylloquinone status (fully adjusted HR 1.12, 95% CI: 0.94, 1.33 for ≤0.5 nmol/L vs. >1.0 nmol/L). However, participants with ≤0.5 nmol/L had a 19% higher risk of all-cause mortality compared with those with >1.0 nmol/L (fully adjusted HR 1.19, 95% CI: 1.03, 1.38).
Shows an association, not proof of cause and effect.
Shea MK, Barger K, Booth SL, et al. Am J Clin Nutr, 2020. PMID 32359159
2020 / Systematic review and meta-analysis of RCTs
A systematic review and meta-analysis of 15 RCTs evaluated the effect of fenugreek supplementation on serum lipids. Compared with control groups, fenugreek significantly reduced total cholesterol (MD -1.13; 95% CI -1.88, -0.37; p = .003), LDL (-1.26; 95% CI -2.09, -0.43; p = .003), and triglycerides (-1.07; 95% CI -1.82, -0.33; p = 0.005), while increasing HDL (0.70; 95% CI 0.07, 1.34; p = .03). In uncontrolled studies, only HDL showed a significant increase (0.81; 95% CI 0.33, 1.29; p = .001). Subgroup analysis indicated that fenugreek reduced triglycerides and LDL and increased HDL more effectively in diabetic subjects, though authors note further high-quality studies are needed.
Heshmat-Ghahdarijani K, Mashayekhiasl N, Amerizadeh A, et al. Phytother Res, 2020. PMID 32385866
2020 / Meta-analysis of prospective cohorts
A meta-analysis of 12 cohort studies examined dietary protein intake and mortality. Higher plant protein intake was associated with lower all-cause mortality (RR 0.92, 95% CI: 0.88 to 0.96 for highest versus lowest; RR 0.97, 95% CI: 0.94 to 0.99 per 3% increment) and may be associated with reduced cardiovascular mortality (RR 0.90, 95% CI: 0.80 to 1.01). Higher animal protein intake was possibly linked to greater cardiovascular death risk (RR 1.11, 95% CI: 1.01 to 1.22). Total protein showed no clear association with mortality.
Shows an association, not proof of cause and effect.
Qi XX, Shen P Nutr Metab Cardiovasc Dis, 2020. PMID 32451273
2020 / Systematic review and meta-analysis of RCTs
A systematic review and meta-analysis of 66 RCTs including 3,185 participants evaluated the effects of egg consumption on blood lipid profiles. Egg consumption significantly increased TC, LDL-C, HDL-C, TC/HDL-C, apoA1, and apoB100, while having no significant effect on other serum lipids or LDL-C/HDL-C ratio. Dose-response analysis revealed a linear effect for TC, HDL-C, ApoA1, and ApoB100, and a nonlinear effect for LDL-C and TC/HDL-C.
Khalighi Sikaroudi M, Soltani S, Kolahdouz-Mohammadi R, et al. J Food Biochem, 2020. PMID 32524644
2020 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis of 17 RCTs evaluated the effects of more egg consumption (MEC) on lipid profiles in healthy populations. Pooled analyses using a random-effects model found that the MEC group had a significantly higher LDL-c/HDL-c ratio (MD = 0.14, p = 0.001, I2 = 25%) and higher LDL-c (MD = 8.14, p < 0.0001, I2 = 18%) compared to control groups. Subgroup analyses showed that interventions lasting over two months appeared to have larger effect sizes than those lasting two months or less. The authors note that RCTs with long-term follow-up are needed to confirm the relationship between egg consumption and human health.
Li MY, Chen JH, Chen C, et al. Nutrients, 2020. PMID 32635569
2020 / Systematic review and meta-analysis
A systematic review and meta-analysis evaluated risk factors, comorbidities, pharmacotherapy, and reversal of premature graying of hair (PGH). Smoking, vitamin deficiencies (B12, folic acid, and B7), and mineral deficiencies (low serum calcium and serum ferritin) were found to be associated with PGH. Other associated factors included obesity, high blood pressure, lack of exercise, and CAD. Low-grade recommendation (2A) was given to calcium pantothenate, PABA, and their combination, and treating accompanying pathologies led to disease reversal in many cases.
Shows an association, not proof of cause and effect.
Mahendiratta S, Sarma P, Kaur H, et al. Dermatol Ther, 2020. PMID 32654282
2020 / Systematic review and meta-analysis of administrative cohort studies
A systematic review and meta-analysis of 18 administrative database cohort studies evaluated 1,539,904 individuals (269,818 undergoing bariatric surgery and 1,270,086 controls) with at least 18 months of follow-up. Bariatric surgery was associated with reduced all-cause mortality (POR 0.62, 95% CI 0.55 to 0.69, p < 0.001) and cardiovascular mortality (POR 0.50, 95% CI 0.35 to 0.71, p < 0.001). It was also linked to reduced incidence of T2DM (POR 0.39), hypertension (POR 0.36), dyslipidaemia (POR 0.33), and ischemic heart disease (POR 0.46). Key limitations include inability to account for unmeasured variables due to non-randomised designs, heterogeneity in control groups, and lack of data on potential adverse surgical outcomes.
Shows an association, not proof of cause and effect.
Wiggins T, Guidozzi N, Welbourn R, et al. PLoS Med, 2020. PMID 32722673
2020 / Meta-analysis of prospective cohort studies
A systematic review and meta-analysis of 16 prospective cohort studies examined the relationship between flavonoid intake and mortality across 462,194 participants followed for 4.8 to 28 years. Flavonoid consumption was inversely and significantly associated with total mortality (RR: 0.87, 95% CI: 0.77-0.99) and cardiovascular disease mortality (RR: 0.85, 95% CI: 0.75-0.97). No significant association was found with cancer mortality risk (RR: 0.86, 95% CI: 0.65-1.14).
Shows an association, not proof of cause and effect.
Mazidi M, Katsiki N, Banach M Nutrients, 2020. PMID 32781562
2020 / Systematic review and meta-analysis of randomized controlled trials
A meta-analysis of 12 randomized controlled trials evaluated the effects of taurine supplementation (0.5 to 6 g/d for 15 days to 6 months), primarily in patients with liver or metabolic dysregulation. Taurine significantly reduced systolic blood pressure (WMD: -4.67 mm Hg; 95% CI, -9.10 to -0.25), diastolic blood pressure (WMD: -2.90 mm Hg; 95% CI, -4.29 to -1.52), total cholesterol (WMD: -10.87 mg/dl; 95% CI, -16.96 to -4.79), and triglycerides (WMD: -13.05 mg/dl; 95% CI, -25.88 to -0.22). It had no significant effect on fasting blood glucose (WMD: 0.06 mg/dl), HDL-C (WMD: 0.90 mg/dl), LDL-C (WMD: -6.17 mg/dl), body mass index (WMD: -0.46 kg/m2), or body weight (WMD: -0.47 kg).
Guan L, Miao P Eur J Pharmacol, 2020. PMID 32871172
2020 / Systematic review of randomized controlled trials
A systematic review evaluated 9 randomized controlled trials examining vitamin K1 or vitamin K2 supplementation on surrogate markers of cardiovascular disease in adults. The findings indicated that vitamin K does not consistently prevent the progression of calcification, atherosclerosis, or arterial stiffness, though there may be some benefit in individuals with calcification at study entry. Although supplementation improves the carboxylation of dephosphorylated matrix gla protein, its role in mitigating vascular calcification remains uncertain. The authors noted that studies were heterogeneous, had relatively short follow-up periods, and used varied outcome measures.
Vlasschaert C, Goss CJ, Pilkey NG, et al. Nutrients, 2020. PMID 32977548
2020 / Systematic review of registered and published clinical trials
Researchers systematically reviewed the characteristics of 152 registered and 119 published Panax ginseng clinical trials retrieved from major databases and trial registries. Ginseng was predominantly evaluated in single-center trials with fewer than 200 subjects and treatment durations under 3 months in healthy individuals or patients with conditions including cardiovascular and metabolic diseases. Among the 119 published trials, 95 (79.8%) reported plenty of positive effects for ginseng.
Fan S, Zhang Z, Su H, et al. Biomed Pharmacother, 2020. PMID 33059260
2019 / Systematic review and dose-response meta-analysis of prospective studies
In a meta-analysis of 123 prospective reports, higher intakes of whole grains, fruits, vegetables, and fish were linked to reduced risks of coronary heart disease, stroke, or heart failure. Red meat, processed meat, and sugary drinks were associated with higher risks across all three conditions. Higher egg intake was specifically associated with increased heart failure risk (RR 1.16, 95% CI: 1.03-1.31).
Shows an association, not proof of cause and effect.
NANO counterpoint →
Bechthold A, Boeing H, Schwedhelm C, et al. Crit Rev Food Sci Nutr, 2019. PMID 29039970
2019 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis of 14 randomized controlled trials with 473 overweight and obese participants assessed the effects of ginger intake. Ginger supplementation significantly decreased body weight (SMD -0.66; 95% CI, -1.31, -0.01; P = 0.04), waist-to-hip ratio (SMD -0.49; 95% CI, -0.82, -0.17; P = 0.003), hip ratio (SMD -0.42; 95% CI, -0.77, -0.08; P = 0.01), fasting glucose (SMD -0.68; 95% CI, -1.23, -0.05; P = 0.03), and HOMA-IR (SMD -1.67; 95% CI, -2.86, -0.48; P = 0.006). It also significantly increased HDL-cholesterol (SMD 0.40; 95% CI, 0.10, 0.70; P = 0.009). No significant effects were observed for BMI, insulin, triglycerides, total cholesterol, or LDL-cholesterol.
Maharlouei N, Tabrizi R, Lankarani KB, et al. Crit Rev Food Sci Nutr, 2019. PMID 29393665
2019 / Systematic review and meta-analysis
A meta-analysis of 16 observational studies with 261,732 adults evaluated dietary sodium, sodium-to-potassium ratio, and stroke risk. Each 1 g/d increase in dietary sodium was associated with higher stroke risk (RR 1.06, 95% CI 1.02 to 1.10; 14 studies), and each one-unit increase in sodium-to-potassium ratio showed an elevated risk (RR 1.22, 95% CI 1.04 to 1.41; 5 studies). Linear dose-response associations were observed without evidence of a J- or U-shaped curve.
Jayedi A, Ghomashi F, Zargar MS, et al. Clin Nutr, 2019. PMID 29907351
2019 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis of 9 randomized controlled trials (n = 664) evaluated the effects of vegetarian dietary patterns lasting at least 3 weeks in people with diabetes. Vegetarian diets significantly reduced HbA1c (MD = -0.29%), fasting glucose (MD = -0.56 mmol/L), LDL-C (MD = -0.12 mmol/L), non-HDL-C (MD = -0.13 mmol/L), body weight (MD = -2.15 kg), BMI (MD = -0.74 kg/m2), and waist circumference (MD = -2.86 cm). No significant effects were observed for fasting insulin, HDL-C, triglycerides, or blood pressure. Overall evidence certainty assessed by GRADE was moderate, but was low for fasting insulin, triglycerides, and waist circumference.
Viguiliouk E, Kendall CW, Kahleová H, et al. Clin Nutr, 2019. PMID 29960809
2019 / Systematic review and meta-analysis of observational studies
Researchers analyzed 28 reports examining potato intake and chronic disease risks. Total potato consumption showed no associations with all-cause mortality (RR 0.88, 95% CI 0.69-1.12), coronary heart disease, stroke, or colorectal cancer per 150 g/day increase. Conversely, each 150 g/day increase in French fries intake was linked to higher risks of type 2 diabetes (RR 1.66, 95% CI 1.43-1.94) and hypertension (RR 1.37, 95% CI 1.15-1.63), based on mostly low- to moderate-certainty evidence.
Shows an association, not proof of cause and effect.
Schwingshackl L, Schwedhelm C, Hoffmann G, et al. Eur J Nutr, 2019. PMID 29987352
2019 / Systematic review and meta-analysis
A systematic review and meta-analysis of 33 studies evaluated the effects of garlic compared with placebo in 1,273 individuals with diabetes. Garlic was associated with significant decreases in total cholesterol by 16.87 mg/dl (95% CI, -21.01 to -12.73; P=0.001), LDL by 9.65 mg/dl (95% CI, -15.07 to -4.23; P=0.001), triglycerides by 12.44 mg/dl (95% CI, -18.19 to -6.69; P=0.001), fasting blood sugar by 10.90 mg/dl (95% CI, -16.40 to -5.40; P=0.001), and HbA1C by 0.60 mg/dl (95% CI, -0.98 to -0.22; P=0.001). Serum HDL significantly increased by 3.19 mg/dl (95% CI, 1.85 to 4.53; P=0.001).
Shabani E, Sayemiri K, Mohammadpour M Prim Care Diabetes, 2019. PMID 30049636
2019 / Bayesian meta-regression of randomized dietary intervention trials
A Bayesian meta-regression of 55 randomized intervention trials with 2652 subjects evaluated the dose-response relationship between changes in dietary cholesterol (0-1500 mg/d, adjusted for dietary fatty acids) and changes in LDL and HDL cholesterol. Mean predicted increases in LDL cholesterol for each 100 mg/d increase in dietary cholesterol were 1.90, 4.46, and 4.58 mg/dL using linear, nonlinear Michaelis-Menten (MM), and Hill models, respectively. Change in dietary cholesterol was modestly inversely related to circulating HDL cholesterol in men but positively related in women based on linear and MM models. The authors noted that clinical implications of dietary cholesterol-associated HDL changes remain uncertain.
Vincent MJ, Allen B, Palacios OM, et al. Am J Clin Nutr, 2019. PMID 30596814
2019 / Systematic reviews and meta-analyses of prospective cohorts and trials
Researchers analyzed 185 prospective studies and 58 clinical trials examining carbohydrate quality markers. Observational data suggested a 15-30% decrease in all-cause and cardiovascular mortality, coronary heart disease, stroke, type 2 diabetes, and colorectal cancer when comparing highest versus lowest dietary fiber consumers. Clinical trials showed significantly lower bodyweight, systolic blood pressure, and total cholesterol with higher dietary fiber intakes. Similar findings were observed for whole grains, whereas evidence for low glycemic index or load showed smaller or no risk reductions.
Reynolds A, Mann J, Cummings J, et al. Lancet, 2019. PMID 30638909